Related Experiment Videos
Transient neonatal hypoglycemia--long-term effects on neurodevelopmental outcome
Nazan Dalgiç1, Ebru Ergenekon, Sebnem Soysal
1Department of Neonatology, Faculty of Medicine, Gazi University, Ankara, Turkey. nazandalgic@ttnet.net.tr
Journal of Pediatric Endocrinology & Metabolism : JPEM
|April 2, 2002
Summary
Neonatal hypoglycemia, a significant concern affecting 9.18% of infants in this study, can lead to serious complications. Early detection and intervention are crucial for preventing adverse outcomes in newborns.
Area of Science:
- Neonatal Medicine
- Pediatric Endocrinology
- Clinical Pediatrics
Background:
- Neonatal hypoglycemia, defined as blood glucose below 2.2 mmol/l, poses risks for infants.
- Understanding its incidence, causes, and effects is vital for clinical management.
Purpose of the Study:
- To determine the frequency of neonatal hypoglycemia.
- To identify the etiological factors and neurological consequences of neonatal hypoglycemia.
Main Methods:
- A retrospective analysis of 94 infants diagnosed with hypoglycemia over five years in a neonatal intensive care unit.
- Data collected included infant demographics, gestational age, cause of hypoglycemia, treatment duration, and neurological outcomes.
Main Results:
- The incidence of neonatal hypoglycemia was 9.18% (94/1023 infants).
- Infants were categorized as small (SGA), appropriate (AGA), or large (LGA) for gestational age; SGA infants required longer glucose infusions.
- While most infants had normal neurological outcomes, some exhibited language or motor deficits.
Conclusions:
- Neonatal hypoglycemia presents significant acute and chronic risks, even in infants without apparent risk factors.
- Prompt diagnosis and management, often with simple measures, can prevent severe complications.